1-8 of 8
Jiang Qian
Close
Sort by
Journal Articles

Trial in Progress: A Perspective Study of Pan-Oral Triplet Regimen Pomalidomide, Ixazomib and Dexamethasone in Relapsed or Refractory Myeloma Patients

Miao Chen, Li Bao, Wenming Chen, Rong Fu, Rong Guo, Hongmei Jing, Hui Liu, Qinhua Liu, Yanping Ma, Xiuli SUN, Wei Wang, Yafei Wang, Xiaojing Yan, Jiang Qian, Junling Zhuang
Journal: Blood
Blood (2021) 138 (Supplement 1): 4783.
https://doi.org/10.1182/blood-2021-148237
Published: 2021
Journal Articles

Detection of CSRP2 Transcript Levels By Real-Time Quantitative PCR May be a Useful Tool for Monitoring Minimal Residual Disease in B-Cell ALL

Lei-Ming Cao, Li-Xin Wu, Ming-Yue Zhao, Ya-Lan Zhou, Jin-Lan Li, Qiu-Yu Sun, Hao Jiang, Jiang Qian, Lan-Ping Xu, Xiao-Hui Zhang, Kai-Yan Liu, Xiao-Jun Huang, Guo-Rui Ruan
Journal: Blood
Blood (2021) 138 (Supplement 1): 3998.
https://doi.org/10.1182/blood-2021-153511
Published: 2021
Journal Articles

Updated Results of Pivotal Phase 2 Trials of Olverembatinib (HQP1351) in Patients (Pts) with Tyrosine Kinase Inhibitor (TKI)-Resistant BCR-ABL1 T315I -Mutated Chronic- and Accelerated-Phase Chronic Myeloid Leukemia (CML-CP and CML-AP)

Jiang Qian, Dayu Shi, Zongru Li, Yue Hou, Yu Hu, Weiming Li, Xiaoli Liu, Na Xu, Yongping Song, Gongli Zhang, Li Meng, Zhenya Hong, Bingcheng Liu, Yan Li, Suning Chen, Mengxing Xue, Huanling Zhu, He Li, Xin Du, Jin Lou, Xiaohan Zhang, Yang Liang, Yujun Dai, Zi Chen, Qian Niu, Lichuang Men, Dajun Yang, Yifan Zhai, Xiaojun Huang
Journal: Blood
Blood (2021) 138 (Supplement 1): 3598.
https://doi.org/10.1182/blood-2021-153937
Published: 2021
Journal Articles

Updated Safety and Efficacy Results of Phase 1 Study of Olverembatinib (HQP1351), a Novel Third-Generation BCR-ABL Tyrosine Kinase Inhibitor (TKI), in Patients with TKI-Resistant Chronic Myeloid Leukemia (CML)

Jiang Qian, Dayu Shi, Zongru Li, Yazhen Qin, Ting Zhao, Bingcheng Liu, Zi Chen, Qian Niu, Lichuang Men, Hengbang Wang, Dajun Yang, Yifan Zhai, Xiaojun Huang
Journal: Blood
Blood (2021) 138 (Supplement 1): 311.
https://doi.org/10.1182/blood-2021-153065
Published: 2021
Journal Articles

Corticosteroids Plus Intravenous Immunoglobulin Compared with Corticosteroids for the Treatment of Immune Thrombocytopenia in Pregnancy: An Observational Multicenter Study in China

Xiao-Lu Zhu, Jing-Wen Wang, Jian-Liang Shen, Hui Liu, Ru Feng, Cheng-Hong Yin, Ying-Jun Chang, Jiang Qian, PhD, Hao Jiang, MD, Jin Lu, Mei-Ying Liang, Xiao-Hong Zhang, Jian-Liu Wang, Lan-Ping Xu, Kai-Yan Liu, Xiao-Jun Huang, MD, Xiao-Hui Zhang, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 1039.
https://doi.org/10.1182/blood.V130.Suppl_1.1039.1039
Published: 2017
Journal Articles

Determinants of Early Death and Outcomes for Acute Promyelocytic Leukemia in the Arsenic Era: A Real World Study

Honghu Zhu, Jinsong Jia, Jiang Qian, PhD, Hao Jiang, MD, Jin Lu, Bin Jiang, Xiaojun Huang
Journal: Blood
Blood (2017) 130 (Supplement 1): 1340.
https://doi.org/10.1182/blood.V130.Suppl_1.1340.1340
Published: 2017
Journal Articles

Silencing of the inhibitor of DNA binding protein 4 (ID4) contributes to the pathogenesis of mouse and human CLL

Shih-Shih Chen, Rainer Claus, David M. Lucas, Lianbo Yu, Jiang Qian, Amy S. Ruppert, Derek A. West, Katie E. Williams, Amy J. Johnson, Fred Sablitzky, Christoph Plass, John C. Byrd
Journal: Blood
Blood (2011) 117 (3): 862–871.
https://doi.org/10.1182/blood-2010-05-284638
Published: 2011
Includes: Supplemental data
Journal Articles

Pharmacokinetic Results from a Phase 1 Study of a Multi-Targeted Tyrosine Kinase Inhibitor, ABT-869, in Patients with Refractory or Relapsed Acute Myelogenous Leukemia (AML) or Myelodysplastic Syndrome (MDS)

Wendy Stock, MD, Karen WL Yee, MD, Eunice S. Wang, MD, Sari Enschede, MD, Joyce Steinberg, MD, Rod Humerickhouse, MD, PhD, Qin Qin, PhD, Jiang Qian, PhD, Yi-Lin Chiu, PhD, Neeraj Gupta, PhD, Rajendra Pradhan, PhD
Journal: Blood
Blood (2008) 112 (11): 4008.
https://doi.org/10.1182/blood.V112.11.4008.4008
Published: 2008